Horizon looks to the future with massive San Francisco manufacturing, R&D plant

Horizon Therapeutics, once known for its primary care drugs, is looking to pivot further to rare diseases with the FDA scrutinizing its late-stage inflammatory eye disease candidate. In the meantime, Horizon is, well, looking to the horizon with a new manufacturing and R&D facility that could help boost its growing pipeline.